NCT06461780 Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
| NCT ID | NCT06461780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Veterans General Hospital, Taiwan |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-03-18 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-03-18 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
During the immune checkpoint inhibitor therapy (ICIT), most of the patients stay at home, but there is lacking of the studies to explore their physical and psychological distress, financial toxicity, care needs, and quality of life. Therefore, the aims of this program are to (1) explore the immune-related adverse event (irAE) severity, distress, financial toxicity, and quality of life and examine the psychometric testing of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM); (2) establish the LINE group for assessing irAE severity and change trajectory of quality of life in one-year follow-up and (3) combined retrospective chart review and the finding in aim (2) to develop the risk prediction model in order to identify the high risk population.
Eligibility Criteria
Inclusion Criteria: * (1) Patients diagnose cancer and are informed * (2) Aged ≥18 years old * (3) Conscious clear and able to communicate
Contact & Investigator
I-Wen Chang, PHD
STUDY CHAIR
Taipei Veterans General Hospital, Taiwan
Frequently Asked Questions
Who can join the NCT06461780 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06461780 currently recruiting?
Yes, NCT06461780 is actively recruiting participants. Contact the research team at iwchang@vghtpe.gov.tw for enrollment information.
Where is the NCT06461780 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06461780 clinical trial?
NCT06461780 is sponsored by Taipei Veterans General Hospital, Taiwan. The principal investigator is I-Wen Chang, PHD at Taipei Veterans General Hospital, Taiwan. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.